Nerve Growth Factor and Autoimmune Diseases

References

• Waksman B H. Autoimmunity in demyelinating diseases. Ann. NY. Acad. Sci. 1988; 540: 13–24
   PubMedGoogle Scholar
• Derijik R., Berbenbosch F. The immuno-hypo-thalamo-pituitary-adrenal axis and autoimmunity. Int. J. Neurosci. 1991; 59: 91–100
   PubMedGoogle Scholar
• Bolton C., Flower R J. The effects of the anti-glucocorticoid RU38486 on steroid-mediated suspression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci. 1989; 45: 97–104
   PubMed Web of Science ®Google Scholar
• Sternberg E M., Hill J H., Chrousos G P., Kamilaris T., Listwak S J., Gold P W. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl Acad. Sci. USA 1989; 86: 2374–2378
   PubMed Web of Science ®Google Scholar
• Sternberg E M., Young W.S., III, Bernardini R., Calogero A E., Chrousos G P., Gold P W. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl Acad. Sci. USA 1989; 86: 4771–4775
   PubMed Web of Science ®Google Scholar
• Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokata T. Cytokines: coordinators of immune and inflammatory responses. Ann. Rev. Biochem. 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar
• Hartung H P., Schafer B, Heininger K., Toyka K V. Recombinant interleukin-lb stimulates eicosanoid production in rat primary culture astroycytes. Brain Res. 1989; 489: 113–119
   PubMed Web of Science ®Google Scholar
• Frohman E M., Frohman T C., Dustin M L., Vayuvegula B., Choi B., Gupta A. The induction of intercellular adhesion molecules 1 (ICAM-1) expression on human fetal astrocytes by interfcron-g, tumor necrosis factor a, lym-photoxin, and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 1989; 23: 117–124
   PubMed Web of Science ®Google Scholar
• Fontana A., Bodmer S., Frei K. Immunoregulatory factors secreted by astrocytes and glioblastoma cell. Lymphokines 1987; 14: 91–121
   Google Scholar
• Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells. I. Induction of la antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 1985; 134: 3785–3793
   PubMed Web of Science ®Google Scholar
• Sun D. Enhanced interferon-g-induced la-antigen expression by glial cells after previous exposure to this cytokine. J. Neuroimmunol. 1991; 34: 205–214
   PubMedGoogle Scholar
• Lieberman A P., Pitha P M., Shi H S., Shin M L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolisaccharide or a neurotropic virus. Proc. Natl Acad. Sci. USA 1989; 86: 6348–6352
   PubMed Web of Science ®Google Scholar
• Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis fator-alpha by microglia and astrocytes in culture. Brain Res. 1989; 491: 394–397
   PubMed Web of Science ®Google Scholar
• Gordon J R., Galli S J. Mast cells as a source of both preformed and immunologically inducible TNF-a/ cachetin. Nature 1990; 346: 274–276
   PubMed Web of Science ®Google Scholar
• Hartung H P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J J. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 1992; 40: 197–210
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154–1162
   PubMed Web of Science ®Google Scholar
• Snider W D., Johnson E M. Neurotrophic molecules. Ann. Neutral. 1989; 26: 489–506
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R., Aloe L., Alleva E. A role for nerve growth factor in nervous, endocrine and immune systems. Prog. NeuroEndocrinlmmunology 1990; 3: 1–10
   Google Scholar
• Gasser U E., Weskamp G., Otten U., Dravid A R. Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septohippocampal pathyway in rats. Brain Res. 1986; 376: 351–356
   PubMedGoogle Scholar
• Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): at tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem. 1987; 48: 1779–1786
   PubMed Web of Science ®Google Scholar
• Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987; 330: 658–659
   PubMed Web of Science ®Google Scholar
• Steiner P., Pfeilschifter J., Boeckh C, Radeke H., Otten U. Interleukin-lb and tumor necrosis factor-a synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am. J. Physiol. 1991; 261: F792–F798
   PubMed Web of Science ®Google Scholar
• Gadient R A., Cron K C., Otten U. Interleukin-lb and tumor necrosis factor-a synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 1990; 117: 335–340
   PubMed Web of Science ®Google Scholar
• Friedman W J., Larkfors L., Ayer-LeLievre C, Ebendal T., Olson L., Persson H. Regulation of b-nerve growth factor expression by inflammatory mediators in hippo-campal cultures. J. Neurosci. Res. 1990; 27: 374–382
   PubMedGoogle Scholar
• Aloe L., Tuveri M A., Carcassi U., Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arth. Rheum. 1992; 35: 351–355
   PubMed Web of Science ®Google Scholar
• Aloe L., Tuveri M A., Levi-Montalcini R. Studies on carrageenan-induced arthritis in adult rats; presence of nerve growth factor and role of sympathetic innervation. Rheumatol. Int. 1992; 12: 213–216
   PubMedGoogle Scholar
• Aloe L., Probert L., Kollias G., Bracci-Laudiero L., Spillantini M G., Levi-Montalcini R. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors
   Google Scholar
• Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Galeazzi M., Schilter D., Scully J L. Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuro-Report 1993; 4: 563–565
   PubMedGoogle Scholar
• Huang Y P., Perrin L H., Miescher P A., Zubler R H. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J. Immunol. 1988; 141: 827–833
   PubMed Web of Science ®Google Scholar
• Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Buttinelli C, Schilter D., Gillessen S. Multiple sclerosis patients express increased levels of b-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 1992; 147: 9–12
   PubMed Web of Science ®Google Scholar
• Goedert M., Stoeckel K., Otten U. Biological importance of the retrograde transport of nerve growth factor in sensory neurons. Proc. Natl Acad. Sci. USA 1981; 78: 5895–5898
   PubMed Web of Science ®Google Scholar
• Verge V M.K., Richardson P M., Benoit R., Riopelle R J. Histochemical characterization of sensory neurons with high-affinity receptors for nerve growth factor. J. Neurocylol. 1989; 18: 583–591
   PubMedGoogle Scholar
• Brimjoin S., Lundberg J M., Brodin E., Hokfelt T., Nilsson G. Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig brain. Brain Res. 1980; 191: 443–457
   PubMed Web of Science ®Google Scholar
• Jessell T M. Central interactions at the central and peripheral terminals of primary sensory neurons. J. Immunol. 1985; 135: 746s–749s
   PubMed Web of Science ®Google Scholar
• Lindsay R M., Harmar A J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362–364
   PubMed Web of Science ®Google Scholar
• Donaldson L F., Harmar A J., McQueen D S., Scckl J R. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal polypeptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Mol. Brain Res. 1992; 16: 143–149
   PubMedGoogle Scholar
• Dubner R., Ruda M A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 1992; 15: 96–103
   PubMed Web of Science ®Google Scholar
• Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49: 693–698
   PubMed Web of Science ®Google Scholar
• Light A R., Perl E R. Spinal termination of functionally identified primary afferent fibres with slowly conducting myelinating fibres. J Comp. Neurol. 1979; 186: 133–143
   PubMed Web of Science ®Google Scholar
• Pernow B. Role of tachykinins in neurogenic inflammation. J. Immunol. 1985; 135: 812s–815s
   PubMed Web of Science ®Google Scholar
• Bynke G. Capsaicin pretreatment prevents disruption of the blood-aqueous barrier in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 1983; 24: 744–749
   PubMed Web of Science ®Google Scholar
• Lewin G R., Ritter A M., Mendell L M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 1993; 13: 2136–2148
   PubMed Web of Science ®Google Scholar
• Treede R D., Meyer R A., Raja S N., Campbell J N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 1992; 38: 397–421
   PubMed Web of Science ®Google Scholar
• Aloe L., Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 1977; 133: 358–366
   PubMed Web of Science ®Google Scholar
• Stead R H., Tomioka M., Quinonez G., Simon G T., Felten S Y., Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected intestines are in intimate contact with peptidergic nerves. Proc. Natl Acad. Sci. USA 1987; 84: 2975–5979
   PubMed Web of Science ®Google Scholar
• Aloe L., De Simone R. NGF primed spleen cells injected in brain of developing rats differentiate into mast cells. Int. J. Devi. Neurosci. 1989; 7: 565–573
   PubMedGoogle Scholar
• Aloe L. The effect of nerve growth factor and its antibody on mast cells in vivo. J. Neuroimmunol. 1988; 18: 1–12
   PubMed Web of Science ®Google Scholar
• Bruni A., Bigon E., Boarato E., Mietto L., Leon A., Toffano G. Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS. Lett. 1982; 138: 190–192
   PubMed Web of Science ®Google Scholar
• Pearce F L., Thompson H L. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J. Physiol. 1986; 372: 379–393
   PubMed Web of Science ®Google Scholar
• Manning P T., Russell J H., Simmons B., Johnson E M. Protection from guanethidine-induced neuronal destruction by nerve growth factor: effects of NGF on immune function. Brain Res. 1985; 340: 61–69
   PubMedGoogle Scholar
• Thorpe L W., Perez-Polo J R. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J. Neurosci. Res. 1987; 18: 134–139
   PubMed Web of Science ®Google Scholar
• Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Nail Acad. Sci. USA 1989; 86: 10059–10063
   PubMed Web of Science ®Google Scholar
• Brodie C., Gelfand E W. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J. Immunol. 1992; 148: 3492–3497
   PubMed Web of Science ®Google Scholar
• Kimata H., Yoshida A., Ishioka G, Kusunoki T., Hosoi S., Mikawa H. Nerve growth factor specifically induces human IgG4 production. Eur. J. Immunol. 1991; 21: 137–141
   PubMedGoogle Scholar
• Thorpe L W., Werrbach-Pcrez K., Perez-Polo J R. Effects of nerve growth factor expression on interleukin-2 receptors on cultured human lymphocytes. Ann. NY. Acad. Sci. 1987; 496: 310–311
   PubMed Web of Science ®Google Scholar
• Matsuda H., Coughlin M D., Bienestock J., Denburg J A. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl Acad. Sci. USA 1988; 85: 6508–6512
   PubMedGoogle Scholar
• Gee A P., Boyle M D.P., Munger K L., Lawman M J.P., Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc. Natl Acad. Sci. USA 1983; 80: 7215–7218
   PubMed Web of Science ®Google Scholar
• Boyle M D.P., Lawman M J.P., Gee A P., Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 1985; 134: 564–568
   PubMed Web of Science ®Google Scholar
• Meakin S O., Shooter E M. The nerve growth factor family of receptors. Trends Neurosci. 1992; 15: 323–331
   PubMed Web of Science ®Google Scholar
• Green S H., Rydel R E., Connolly J L., Greene L. A. PC 12 mutants that possess low but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor. J. Cell Biol. 1986; 102: 830–843
   PubMed Web of Science ®Google Scholar
• Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene 1993; 8: 2033–2042
   PubMedGoogle Scholar
• Morgan B., Thorpe L W., Marchetti D., Perez-Polo J R. Expression of nerve growth factor receptors by human peripheral blood mononuclear cells. J. Neurosci. Res. 1989; 23: 41–45
   PubMed Web of Science ®Google Scholar
• Enrhard P B., Ganter U., Bauer J., Otten U. Expression of functional trie protooncogene in human monocytes. Proc. Natl Acad. Sci. USA 1993; 90: 5423–5427
   PubMedGoogle Scholar
• Ehrhard P B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl Acad. Sci. USA 1990; 90: 10984–10988
   Google Scholar
• Horigome K., Pryor J C., Bullock E D., Johnson E M. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J. Biol. Chem. 1993; 268: 14881–14887
   PubMed Web of Science ®Google Scholar
• Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl Acad. Sci. USA 1994; 91: 3739–3743
   PubMed Web of Science ®Google Scholar
• Felten D L., Feltein S Y., Carlson S L., Olschowka J A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985; 135: 755s–765s
   PubMed Web of Science ®Google Scholar
• Abramchik G V., Yermakova S S., Kaliunov V N., Tanina R M., Tumilovich M K. The immunomodulatory effect of nerve growth factor. J. Neurosci. Res. 1988; 19: 349–356
   PubMed Web of Science ®Google Scholar
• Ernfors P., Hallbook F., Ebendal T., Shooter E M., Radeke M J., Misko T P. Developmental and regional expression of b-nerve growth factor receptor mRNA in the chick and rat. Neuron. 1988; 1: 983–996
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R., Angeletti P U. Immunosympath-ectomy. Pharmacol. Rev. 1966; 18: 619–628
   PubMed Web of Science ®Google Scholar
• Aloe L., Alleva E., De Simone R. Changes of NGF level in mouse hypothalamus following intermale aggressive behavior: biological and immunohistochemical evidence. Behav. Brain Res. 1990; 39: 53–61
   PubMedGoogle Scholar
• Persson H., Ayer-Le Lievre C., Sbder O, Villar M J., Madis Metsis M., Olson L. Expression of b-nerve growth factor receptor mRNA in Sertoli cells downregu-lated by testosterone. Science 1990; 247: 704–707
   PubMed Web of Science ®Google Scholar
• Lara H E., McDonald J K., Ojeda S R. Involvement of nerve growth factor in female sexual development. Endocrinology 1990; 126: 364–375
   PubMed Web of Science ®Google Scholar
• Spillantini M G., Aloe L., Alleva E., De Simone R., Goedert M., Levi-Montalcini R. Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc. Natl Acad. Sci. USA 1989; 86: 8555–8559
   PubMed Web of Science ®Google Scholar
• Ojeda S R., Hill D F., Katz K H. The genes encoding nerve growth factor and its receptor are expressed in the developing female rat hypothalamus. Mol. Brain Res. 1991; 9: 47–55
   PubMedGoogle Scholar
• Lahtinen T., Soinila S., Lakshmanan J. Biological demonstration of nerve growth factor in the rat pituitary gland. Neuroscience 1989; 30: 165–170
   PubMedGoogle Scholar
• Dicou E., Lee J., Brachet P. Synthesis of nerve growth factor mRNA and precursor protein in the thyroid and parathyroid glands of the rat. Proc. Natl Acad. Sci. USA 1986; 83: 7084–7088
   PubMed Web of Science ®Google Scholar
• Otten U., Baumann J B., Girard J. Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 1979; 282: 413–414
   PubMed Web of Science ®Google Scholar
• Luppi P., Levi-Montalcini R., Bracci-Laudiero L., Berto-Lini A., Arletti R., Tavernari D. NGF is released into plasma during human pregnancy: an oxytocin-mediated response?. NeuroReport 1993; 4: 1063–1065
   PubMedGoogle Scholar
• Missalc C, Boroni F., Losa M., Giovanelli M., Zanellato A., Dal Toso R. Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc. Natl Acad. Sci. USA 1993; 90: 7961–7965
   PubMedGoogle Scholar
• Missale C, Boroni F., Sigala S., Zanellato A., Dal Toso R., Balsari A. Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype. Endocrinology 1994; 135
   PubMedGoogle Scholar
• Aloe L., Cozzari C, Calissano P., Levi-Montalcini R. Somantic and behavioral postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature 1981; 291: 413–415
   PubMed Web of Science ®Google Scholar
• Johnson E M., Osborne P A., Rydel R E., Schmidt R E., Pearson J. Characterization of the effects of autoimmune nerve growth factor deprivation in the developing guinea pig. Neuroscience 1983; 8: 631–642
   PubMed Web of Science ®Google Scholar
• Yip H K., Rich K M., Lampe P A., Johnson E M. The effects of nerve growth factor and its antiserum on the postnatal development and survival after injury of sensory neurons in rat dorsal root ganglia. J. Neurosci. 1984; 4: 2986–2992
   PubMed Web of Science ®Google Scholar
• Dicous E., Hurez D., Nerriere V. Natural autoantibodies against nerve growth factor in autoimmune diseases. J. Neuroimmunol. 1993; 47: 159–168
   PubMedGoogle Scholar
• Dicou E., Nerriere V., Labropoulou V. Naturally occurring antibodies against nerve growth factor in human and rabbit sera: comparison between control and herpes simplex virus-infected patients. J. Neuroimmunol. 1991; 34: 153–158
   PubMedGoogle Scholar
• Aloe L., Alleva E., Bohm A., Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc. Natl Acad Sci. USA 1986; 83: 6184–6187
   PubMed Web of Science ®Google Scholar
• Maestripieri D., De Simone R., Aloe L., Levi-Montalcini R. Social status and nerve growth factor serum levels after agonistic encounters in mice. Physiol. Behav. 1990; 47: 161–164
   PubMedGoogle Scholar
• Galli S J., Dvorak A M., Dvorak H F. Basophils and mast cells: morphologic insights into their biology, secretory patterns and function. Prog. Allergy 1984; 34: 1–141
   PubMedGoogle Scholar
• Bienenstock J., Tomioka M., Matsuda H., Stead R H., Quinonez G., Simon G T. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int. Arch. Allergy Apply Immunol. 1987; 82: 238–243
   PubMedGoogle Scholar
• Johnson D., Krenger W. Interactions of mast cells with the nervous system-recent advances. Neurochem. Res. 1992; 9: 939–951
   Google Scholar
• Olsson Y. Mast cells in the nervous system. Int. Rev. Cytol. 1968; 24: 27–70
   PubMedGoogle Scholar
• Gordon J R., Burd P R., Galli S J. Mast cells as a source of multifunctional cytokines. Immunol. Today 1990; 11: 458–464
   PubMedGoogle Scholar
• Tuveri M A., Passiu G., Mathieu A., Aloe L. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin. Exp. Rheumatol. 1993; 11: 319–322
   PubMed Web of Science ®Google Scholar
• Aloe L., Tuveri M A., Levi-Montalcini R. Nerve growth factor and distribution of mast cells in the synovium of adult rats. Clin. Exp. Rheumatol. 1992; 10: 203–204
   PubMedGoogle Scholar
• Otten U., Baumann J B., Girard J. Nerve growth factor induces plasma extravasation in rat skin. Eur. J. Pharmacol. 1984; 106: 199–201
   PubMedGoogle Scholar
• Bischoff S C., Dahinden C A. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992; 79: 2662–2669
   PubMed Web of Science ®Google Scholar
• Galli S J., Gordon J R., Wershil B K. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 1991; 3: 865–872
   PubMed Web of Science ®Google Scholar
• Stead R H., Kosecka-Janiszewska U., Oestrcicher A B., Dixon M F., Bienenstock J. Remodelling of B-50 (GAP-43)-and NSE-immunoreactive mucosal nerves in the intestines of rats with Nippostrongvlus hrasiliensis. J. Neurosci. 1991; 11: 3809–3821
   PubMedGoogle Scholar
• Blennerhasset M G, Tomioka M., Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res. 1991; 265: 121–128
   PubMedGoogle Scholar
• Sant G R. Interstitial cystitis: pathophysiology, clinical evaluation and treatment. Urol. Ann. 1989; 3: 172–179
   Google Scholar
• Theoharides T C, Dimitriadou V., Letourneau R., Rozniecki J J., Vliagoftis H., Boucher W. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 1993; 57: 861–871
   PubMedGoogle Scholar
• Johnson D., Seeldrayers P A., Weiner H L. The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 1988; 444: 195–198
   PubMedGoogle Scholar
• Theoharides T C., Baloyannis S J., Manolidis L S. Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int. J. Immunopath. Pharmacol. 1991; 4: 137–144
   Google Scholar
• Lambracht-Hall M., Dimitriadou V., Theoharides T C. Migration of mast cells in the developing rat brain. Dev. Brain Res. 1990; 56: 151–159
   PubMedGoogle Scholar
• Lambracht-Hall M., Konstantinidou A D., Theoharides T C. Serotonin release from rat brain mast cells in vitro. Neuroscience 1990; 30: 199–207
   Google Scholar
• Hauser S L., Bhan A K., Gilles F., Kemp M., Kerr C., Weiner H L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 1986; 19: 578–587
   PubMed Web of Science ®Google Scholar
• Prineas J W., Wright R G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 1978; 38: 409–421
   PubMed Web of Science ®Google Scholar
• Sobel R A., Blanchette B W., Bhan A K., Colvin R B. The immunopathology of experimental allergic encephalomyelitis: quantitative analysis of inflammatory cells in situ. J. Immunol. 1984; 132: 2393–2401
   PubMed Web of Science ®Google Scholar
• Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 1974; 50: 611–618
   PubMedGoogle Scholar
• Toms R., Weiner H L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuoimmunol. 1990; 30: 169–177
   PubMed Web of Science ®Google Scholar
• Theoharides T C, Dimitriadou V., Massacesi L., Hauser S L. Ultrastructural evidence of mast cell involvement in monkey experimental allergic encephalomyelitis (EAE). Proc International Congress on Inflammation. Barcelona 1990; 282
   Google Scholar
• Brosnan C F., Lyman W D., Tansey F A., Carter T H. Quantitation of mast cells in experimental allergic neuritis. J. Neuropath. Exp. Neurol. 1985; 44: 196–203
   PubMedGoogle Scholar
• Askenase P W., van Loveren H. Delayed-type hypersensitivity activation of mast cells by antigen-specific T-cell factors initiates the cascade of cellular interactions. Immunol. Today 1983; 4: 259–264
   PubMedGoogle Scholar
• Kaplan A P., Reddigari S., Bacza M., Kuna P. Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv. Immunol. 1991; 50: 237–260
   PubMedGoogle Scholar
• Frandji P., Oskeritzian C, Cacaraci F., Lapeyre J., Peronet R., David B. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted Tcell hybridoma. J. Immunol. 1993; 151: 6318–6328
   PubMed Web of Science ®Google Scholar
• Reddy E., Sanberg-Wollheim M., Mettus R V., Ray P E., De Freitas E., Koprowski H. Amplification and molecular cloning of HTLV-1 sequences from DNA of multiple sclerosis patients. Science 1989; 243: 529–533
   PubMed Web of Science ®Google Scholar
• Vandvik B., Norrby E. Paramyxovirus SV5 and multiple sclerosis. Nature 1989; 338: 769–771
   PubMedGoogle Scholar
• Mokhtarian F., Griffin D E. The role of mast cells in virus-induced inflammation in the murine central nervous system. Cell Immunol. 1984; 86: 491–500
   PubMedGoogle Scholar
• Sugiyama K. Histamine release from rat mast cells induced by Sendai virus. Nature 1977; 270: 614–615
   PubMedGoogle Scholar
• Mosmann T R., Coffman R I. Two types of mouse T helper cell clone: implication for immune regulation. Immunol. Today 1987; 8: 223–226
   PubMedGoogle Scholar
• Mosmann T R., Coffman R I. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–168
   PubMed Web of Science ®Google Scholar
• Fiorentino D F., Bond M W., Mosmann T R. Two types of mouse T helper cells. IV. The clones secrete a factor that inhibits cytokines production by Thl clones. J. Exp. Med. 1989; 170: 2081–2098
   PubMed Web of Science ®Google Scholar
• Clerici M., Shearer G M. A TH1 ÆTH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993; 14: 107–111
   PubMedGoogle Scholar
• Costa J J., Burd P R., Metcalfe D D., Kaliner M A., Metcalfe D D. Mast cell cytokines. The Mast Cell in Health and Disease Vol. 62. M. Dekker, New York 1993; 443–466
   Google Scholar
• Malone D G., Metcalfe D D. Mast cells and arthritis. Ann. Allergy 1988; 61: 27–30
   PubMedGoogle Scholar
• Mican J M., Metcalfe D D. Arthritis and mast cell activation. J. Allergy Appl. Immunol. 1990; 86: 677–683
   PubMed Web of Science ®Google Scholar
• Orr R L. Nervous system-associated mast cells: gatekeepers of neural and immune interactions. Drug. Dev. Res. 1988; 15: 195–205
   Google Scholar
• Lavker R M., Schechter N M., Guzzo C., Lazarus G S. Aggressive topical corticosteroid therapy: a novel approach to mast cell-dependent cutaneous disorders. Dermatologica 1987; 175: 213–216
   PubMedGoogle Scholar
• Bachclct CM., Bcrnaudin J F., Fleury-Feith J. Histological study of mast cells in the actively sensitized guinea pig lung and after challenge: effect of a corticosteroid. Int. Arch. Allergy Appl. Immunol. 1990; 91: 171–174
   PubMedGoogle Scholar
• Aloe L., Leon A., Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993; 39: C145–C147
   PubMedGoogle Scholar
• Mazzari S., Canella R., Marcolongo G., Leon A. N-(α-hydroxyethyl) hexadecanamide given orally reduces hyperalgesia by down-modulating mast cell activation. Soc. Neurosci Ahstr. 1994
   Google Scholar